Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Polycystic Ovary Syndrome Risk: A Meta Analysis

PURPOSE: Several studies have reported that excessive amounts of plasminogen activator inhibitor-1(PAI-1) might increase the incidence of polycystic ovary syndrome(PCOS), but so far the published results were inconsistent. The aim of this study was to further investigate the association between PAI-...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Liu, Ying, Sun, Mei-Guo, Jiang, Rong, Ding, Rui, Che, Zhen, Chen, Yan-Yan, Yao, Ci-Jiang, Zhu, Xiao-Xia, Cao, Ji-Yu
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer US 2014
נושאים:
Gonadal Physiology and Disease
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947070/
https://ncbi.nlm.nih.gov/pubmed/24435452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10815-013-0171-2
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים